🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.

Several experts stated the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, legal action or prison.

Platform Reaction and Material Elimination

Based on the social media company, the service has taken down problematic material and banned related hashtags and search suggestions. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of users, filled with images of weight loss, glowing reviews and detailed guides for mixing or administering at home.

After moments of entering one community, a seller posted WhatsApp details, where most purchases occur. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Item Information and Pricing

Inside these communities, posts display dark colored packages with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service said it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to possibly serious health risks”.